PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETER MARKET ANALYSIS

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market, By Product Type (Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter, and Scoring Balloon Catheter), By Ballon Material (Polyolefin copolymer (POC), Polyethylene (PE) and Polyethylene terephthalate (PET)), By Application (Peripheral Artery Disease and Coronary Artery Disease), By End User (Hospitals, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

On August 5, 2024, Teleflex Incorporated, a medical device company, announced that the U.S. Food and Drug Administration (FDA) approved its percutaneous transluminal coronary angioplasty perfusion balloon catheter. The perfusion balloon catheter (Ringer) is a rapid-exchange 0.014” compatible catheter with a helical balloon that, when inflated, approximates a hollow cylinder with a large central perfusion lumen allowing for continuous blood flow during prolonged inflations
On May 3, 2024, Swanson School of Engineering - University of Pittsburgh announced that it had received approximately US$ 1.1 million from the South Korean Ministry of Health and Welfare’s Healthcare Technology Research and Development Project to revolutionize the design of the coronary balloon device
In March 2021, Medtronic, a medical technology company, announced the launch of its Chameleon percutaneous transluminal angioplasty (PTA) balloon catheter in the following countries: Germany, Italy, Portugal, South Africa, Spain, and Turkey. The device is indicated for use in native or synthetic arteriovenous dialysis fistulae, as well as femoral, iliac, and renal arteries.